State Key Laboratory of Animal Nutrition, Institute of Animal Science, Chinese Academy of Agricultural Sciences, Yuanmingyuan West Road 2, Beijing 100193, China.
China Institute of Veterinary Drug Control, Beijing 100081, China.
Avian Dis. 2020 Sep 1;64(3):393-400. doi: 10.1637/aviandiseases-D-19-00101.
This study was conducted to investigate the effects of replacing in-feed antibiotics with synergistic organic acids on growth performance, health, carcass, and immune and oxidative statuses of broiler chickens under Clostridium perfringens (CP) type A challenge. Two organic acid products were tested: organic acid 1 (OA1), consisting of butyrate, medium-chain fatty acids, organic acids, and phenolics; and organic acid 2 (OA2), consisting of buffered short-chain fatty acids. Six hundred 1-day-old male Arbor Acres broiler chicks were randomly assigned to one of five treatments: Control 1, basal diet, nonchallenged birds; Control 2, basal diet, with CP challenge; antimicrobial growth promoters (AGP), basal diet supplemented with Aureomycin (chlortetracycline), with CP challenge; OA1, basal diet supplemented with OA1, with CP challenge; and OA1OA2, basal diet supplemented with OA1 and OA2, with CP challenge. Each treatment had eight replicate pens of 15 birds. The experiments lasted for 29 days. The disease challenge was performed on days 15-17, with an oral gavage of 0.5 mL of CP culture (2.0 × 108 colony-forming units [CFU]/mL) for each bird. Body weights (BWs), intestinal lesion scores, immune organ indices, and serum malondialdehyde (MDA) concentrations were measured on days 19, 22, and 29, respectively, in three birds per pen. Carcass characteristics were determined on day 29. No treatment-related differences in mortality were noted before (P = 0.28) or after (P = 0.64) challenge or over the whole study period (days 0-28; P = 0.66). On day 19, the BW of Control 2 was lower than other treatments (P < 0.0001). On day 22, AGP, OA1, and OA1OA2 had higher BW than Control 2 (P = 0.001). The breast muscle yield of OA1 and OA1OA2 was higher than AGP (P < 0.05). The abdominal fat yield of OA1OA2 was lower than AGP and Control 2 (P < 0.05). On day 22, the birds fed OA1OA2 showed lower intestinal lesion scores than OA1 (P < 0.05). No treatment-related differences in immune organ (spleen, thymus, and bursa) indices were noted (P > 0.05). On day 29, the MDA concentration of OA1 and OA1OA2 was lower than those of Control 1 and AGP (P < 0.05). In conclusion, the addition of organic acids may protect broiler chickens from severe intestinal lesions and oxidative stress and may help reduce abdominal fat mass deposition. There is potential for organic acid-based products as alternatives for AGP in preventing necrotic enteritis in broilers.
本研究旨在探讨在产气荚膜梭菌(CP)A型挑战下,用协同有机酸替代饲料中的抗生素对肉鸡生长性能、健康状况、胴体、免疫和氧化状态的影响。测试了两种有机酸产品:有机酸 1(OA1),由丁酸盐、中链脂肪酸、有机酸和酚类物质组成;有机酸 2(OA2),由缓冲短链脂肪酸组成。600 只 1 日龄雄性 Arbor Acres 肉鸡被随机分配到五个处理组之一:对照 1,基础日粮,未受挑战的鸟类;对照 2,基础日粮,CP 挑战;抗菌生长促进剂(AGP),基础日粮添加金霉素(土霉素),CP 挑战;OA1,基础日粮添加 OA1,CP 挑战;OA1OA2,基础日粮添加 OA1 和 OA2,CP 挑战。每个处理组有 8 个重复 15 只鸟的笼位。实验持续 29 天。疾病挑战于第 15-17 天进行,每只鸡口服灌胃 0.5 毫升 CP 培养物(2.0×108 菌落形成单位[CFU]/毫升)。分别于第 19、22 和 29 天,每笼 3 只鸡测量体重(BW)、肠道病变评分、免疫器官指数和血清丙二醛(MDA)浓度。第 29 天测定胴体特性。在挑战前(P=0.28)或挑战后(P=0.64)或整个研究期间(第 0-28 天;P=0.66),死亡率均与处理无关。第 19 天,对照 2 的 BW 低于其他处理组(P<0.0001)。第 22 天,AGP、OA1 和 OA1OA2 的 BW 高于对照 2(P=0.001)。OA1 和 OA1OA2 的胸肌产量高于 AGP(P<0.05)。OA1OA2 的腹部脂肪产量低于 AGP 和对照 2(P<0.05)。第 22 天,饲喂 OA1OA2 的鸡肠道病变评分低于 OA1(P<0.05)。免疫器官(脾脏、胸腺和法氏囊)指数无处理相关差异(P>0.05)。第 29 天,OA1 和 OA1OA2 的 MDA 浓度低于对照 1 和 AGP(P<0.05)。综上所述,添加有机酸可保护肉鸡免受严重的肠道病变和氧化应激,并有助于减少腹部脂肪沉积。有机酸产品有潜力替代 AGP 预防肉鸡坏死性肠炎。